nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurbiprofen—Chlordiazepoxide—GABRA2—conduct disorder	0.151	0.231	CrCbGaD
Flurbiprofen—Clorazepate—GABRA2—conduct disorder	0.141	0.216	CrCbGaD
Flurbiprofen—Nitrazepam—GABRA2—conduct disorder	0.105	0.162	CrCbGaD
Flurbiprofen—Oxazepam—GABRA2—conduct disorder	0.0907	0.139	CrCbGaD
Flurbiprofen—Temazepam—GABRA2—conduct disorder	0.0896	0.138	CrCbGaD
Flurbiprofen—Diazepam—GABRA2—conduct disorder	0.0744	0.114	CrCbGaD
Flurbiprofen—UGT1A3—Estrogen metabolism—COMT—conduct disorder	0.0313	0.0897	CbGpPWpGaD
Flurbiprofen—UGT2B7—Estrogen metabolism—COMT—conduct disorder	0.0266	0.0763	CbGpPWpGaD
Flurbiprofen—UGT1A1—Estrogen metabolism—COMT—conduct disorder	0.0216	0.062	CbGpPWpGaD
Flurbiprofen—UGT1A9—Estrogen metabolism—COMT—conduct disorder	0.0216	0.062	CbGpPWpGaD
Flurbiprofen—UGT2B4—Phase II conjugation—COMT—conduct disorder	0.0164	0.0471	CbGpPWpGaD
Flurbiprofen—UGT2B4—Biological oxidations—COMT—conduct disorder	0.0096	0.0275	CbGpPWpGaD
Flurbiprofen—UGT2B4—Biological oxidations—MAOA—conduct disorder	0.00953	0.0273	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metapathway biotransformation—COMT—conduct disorder	0.00947	0.0272	CbGpPWpGaD
Flurbiprofen—UGT1A3—Phase II conjugation—COMT—conduct disorder	0.00879	0.0252	CbGpPWpGaD
Flurbiprofen—UGT1A3—NRF2 pathway—SLC6A4—conduct disorder	0.00773	0.0222	CbGpPWpGaD
Flurbiprofen—UGT2B7—Phase II conjugation—COMT—conduct disorder	0.00747	0.0214	CbGpPWpGaD
Flurbiprofen—UGT2B7—NRF2 pathway—SLC6A4—conduct disorder	0.00658	0.0189	CbGpPWpGaD
Flurbiprofen—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00633	0.0182	CbGpPWpGaD
Flurbiprofen—ABCC4—NRF2 pathway—SLC6A4—conduct disorder	0.00618	0.0177	CbGpPWpGaD
Flurbiprofen—UGT1A1—Phase II conjugation—COMT—conduct disorder	0.00607	0.0174	CbGpPWpGaD
Flurbiprofen—UGT1A9—Phase II conjugation—COMT—conduct disorder	0.00607	0.0174	CbGpPWpGaD
Flurbiprofen—PTGS1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00541	0.0155	CbGpPWpGaD
Flurbiprofen—UGT1A9—NRF2 pathway—SLC6A4—conduct disorder	0.00534	0.0153	CbGpPWpGaD
Flurbiprofen—UGT1A1—NRF2 pathway—SLC6A4—conduct disorder	0.00534	0.0153	CbGpPWpGaD
Flurbiprofen—UGT1A3—Biological oxidations—COMT—conduct disorder	0.00514	0.0148	CbGpPWpGaD
Flurbiprofen—UGT1A3—Biological oxidations—MAOA—conduct disorder	0.0051	0.0146	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metapathway biotransformation—COMT—conduct disorder	0.00507	0.0145	CbGpPWpGaD
Flurbiprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00437	0.0126	CbGpPWpGaD
Flurbiprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00437	0.0126	CbGpPWpGaD
Flurbiprofen—UGT2B7—Biological oxidations—COMT—conduct disorder	0.00437	0.0125	CbGpPWpGaD
Flurbiprofen—UGT2B7—Biological oxidations—MAOA—conduct disorder	0.00434	0.0125	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metapathway biotransformation—COMT—conduct disorder	0.00431	0.0124	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—CGA—conduct disorder	0.00364	0.0104	CbGpPWpGaD
Flurbiprofen—UGT1A1—Biological oxidations—COMT—conduct disorder	0.00355	0.0102	CbGpPWpGaD
Flurbiprofen—UGT1A9—Biological oxidations—COMT—conduct disorder	0.00355	0.0102	CbGpPWpGaD
Flurbiprofen—UGT1A1—Biological oxidations—MAOA—conduct disorder	0.00353	0.0101	CbGpPWpGaD
Flurbiprofen—UGT1A9—Biological oxidations—MAOA—conduct disorder	0.00353	0.0101	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metapathway biotransformation—COMT—conduct disorder	0.0035	0.0101	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metapathway biotransformation—COMT—conduct disorder	0.0035	0.0101	CbGpPWpGaD
Flurbiprofen—ABCC4—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00312	0.00895	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00302	0.00867	CbGpPWpGaD
Flurbiprofen—PTGS1—Biological oxidations—COMT—conduct disorder	0.0029	0.00831	CbGpPWpGaD
Flurbiprofen—PTGS1—Biological oxidations—MAOA—conduct disorder	0.00288	0.00825	CbGpPWpGaD
Flurbiprofen—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00285	0.00816	CbGpPWpGaD
Flurbiprofen—PTGS2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00283	0.00812	CbGpPWpGaD
Flurbiprofen—SLC22A6—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00271	0.00779	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00246	0.00707	CbGpPWpGaD
Flurbiprofen—UGT1A9—PPARA activates gene expression—EP300—conduct disorder	0.00218	0.00625	CbGpPWpGaD
Flurbiprofen—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00213	0.00612	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00196	0.00561	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—CGA—conduct disorder	0.00195	0.00559	CbGpPWpGaD
Flurbiprofen—PTGS2—C-MYB transcription factor network—EP300—conduct disorder	0.00175	0.00502	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—CGA—conduct disorder	0.00166	0.00475	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—COMT—conduct disorder	0.00164	0.00471	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—MAOA—conduct disorder	0.00163	0.00468	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00158	0.00454	CbGpPWpGaD
Flurbiprofen—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00152	0.00437	CbGpPWpGaD
Flurbiprofen—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00151	0.00434	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.0015	0.00431	CbGpPWpGaD
Flurbiprofen—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00147	0.00421	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00141	0.00405	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—CGA—conduct disorder	0.00135	0.00386	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CGA—conduct disorder	0.00135	0.00386	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00129	0.00372	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CGA—conduct disorder	0.0011	0.00315	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000906	0.0026	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—COMT—conduct disorder	0.000879	0.00252	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—MAOA—conduct disorder	0.000873	0.0025	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CGA—conduct disorder	0.000871	0.0025	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—COMT—conduct disorder	0.000748	0.00214	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—EP300—conduct disorder	0.000743	0.00213	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—MAOA—conduct disorder	0.000742	0.00213	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CGA—conduct disorder	0.000705	0.00202	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—EP300—conduct disorder	0.000704	0.00202	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—COMT—conduct disorder	0.000607	0.00174	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—COMT—conduct disorder	0.000607	0.00174	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—MAOA—conduct disorder	0.000603	0.00173	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—MAOA—conduct disorder	0.000603	0.00173	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000585	0.00168	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CGA—conduct disorder	0.000577	0.00165	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—COMT—conduct disorder	0.000495	0.00142	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—MAOA—conduct disorder	0.000492	0.00141	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000477	0.00137	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—COMT—conduct disorder	0.000393	0.00113	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—MAOA—conduct disorder	0.00039	0.00112	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000379	0.00109	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—EP300—conduct disorder	0.000377	0.00108	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—EP300—conduct disorder	0.000336	0.000965	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—EP300—conduct disorder	0.000321	0.00092	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—COMT—conduct disorder	0.000318	0.000913	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—MAOA—conduct disorder	0.000316	0.000906	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000306	0.000879	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—EP300—conduct disorder	0.00026	0.000747	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—EP300—conduct disorder	0.00026	0.000747	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—COMT—conduct disorder	0.00026	0.000747	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—MAOA—conduct disorder	0.000258	0.000742	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000251	0.000719	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—EP300—conduct disorder	0.000212	0.000609	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—EP300—conduct disorder	0.000201	0.000578	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—EP300—conduct disorder	0.000169	0.000484	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—EP300—conduct disorder	0.000136	0.000391	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—EP300—conduct disorder	0.000112	0.00032	CbGpPWpGaD
